glp-1 drugs fda approved for weight loss The has the first pill version of drugs. Novo Nordisk says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body GLP-1 Safety Check - National

The new medications often target multiple receptors

Stimulation of -cell proliferation secondary to stimulating GLP-1R is usually only observed in young animals (during periods characterized by preserved proliferative capacity), and not in older rodents [548]

Effect of insulin on excitatory synaptic transmission onto dopamine neurons of the ventral tegmental area in a mouse model of hyperinsulinemia

A 2025 perspective suggested GLP-1s may influence epigenetic processes involved in age-related liver fibrosis and cancer risk [6]

proved GLP-1 receptor activation by inducing the cAMP/PKA pathway in macrophages inhibits atherosclerosis through regulation of inflammatory process

doi: 10.1038/ijo.2011.158 [DOI] [PMC free article] [PubMed] [Google Scholar] 240